A phase I/Il Study of erlotinib (Tarceva) in combination with cisplatin in patients with recurrent or metastatic squamous cell cancer of the head and neck (HNSCC). Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Siu, LL
  • Chen, X
  • Tsao, M
  • Dancey, J
  • Pond, Gregory
  • Klein, M
  • Winquist, E

publication date

  • December 1, 2003